By using this site, you agree to the Privacy Policy and Terms of Use.
Accept
Health Works CollectiveHealth Works CollectiveHealth Works Collective
  • Health
    • Mental Health
  • Policy and Law
    • Global Healthcare
    • Medical Ethics
  • Medical Innovations
  • News
  • Wellness
  • Tech
Search
© 2023 HealthWorks Collective. All Rights Reserved.
Reading: Popular Smoking Cessation Drug Increases Adverse Cardiac Risk
Share
Notification Show More
Font ResizerAa
Health Works CollectiveHealth Works Collective
Font ResizerAa
Search
Follow US
  • About
  • Contact
  • Privacy
© 2023 HealthWorks Collective. All Rights Reserved.
Health Works Collective > Business > Popular Smoking Cessation Drug Increases Adverse Cardiac Risk
Business

Popular Smoking Cessation Drug Increases Adverse Cardiac Risk

MichaelDouglas1
MichaelDouglas1
Share
0 Min Read
SHARE

First, and almost immediately out of the box, it was the concern for serious mental health effects.[1] Now, somewhat controversial smoking cessation drug varenicline (Chantix) First, and almost immediately out of the box, it was the concern for serious mental health effects.[1] Now, somewhat controversial smoking cessation drug varenicline (Chantix) is the target of the FDA with respect to the increased risk of heart disease for those taking it. Of course, the FDA rates this as only a “small” risk as it “continues to evaluate its safety”.

The new warning comes from a 700-person trial in which patients who took Chantix (varenicline) over 12 weeks were more likely to experience an adverse heart event after one year than those who received a placebo. All of the patients had already been diagnosed with heart disease. For both groups, the heart attack risk was still small: 7 out of 353 patients taking Chantix had a nonfatal heart attack, versus 3 out of 350 who took a placebo.

  1. Pfizer, the drug’s manufacturer was also the target of claims of an increased risk of suicidal ideation for those taking the drug — to a lesser extent, night terrors and delirium.

Related posts:

  1. NEJM Study: Two Popular Blood Thinners Effective for Stroke Risk Reduction in Appropriate Candidates No April Fool’s Joke here. A new study shows combining…
  2. Saturday Briefs in Cardiac Medical News Vanderbilt University (my undergrad alma mater) has announced that it…
  3. NEJM: Intensive Antidiabetic Treatment with Respect to Cardiac Risk Factors in Diabetics Harmful Diabetes mellitus, type 2 is an epidemic problem in the…

 

TAGGED:chantixhealthcare businesssmoking
Share This Article
Facebook Copy Link Print
Share

Stay Connected

1.5kFollowersLike
4.5kFollowersFollow
2.8kFollowersPin
136kSubscribersSubscribe

Latest News

dental care
Importance of Good Dental Care for Health and Confidence
Dental health Specialties
October 2, 2025
AI in Healthcare
AI in Healthcare: Technology is Transforming the Global Landscape
Global Healthcare Policy & Law Technology
October 1, 2025
Choosing the Right Swimwear for Health and Safety
News
September 30, 2025
sports concussions
Concussion In Sports: How Common They Are And What You Need To Know
Infographics
September 28, 2025

You Might also Like

Better, Smarter, Healthier: Medicare and Value Based Purchasing

February 3, 2015
hospital cyber attack
BusinesseHealthNews

Two Hospital PR Case Examples: One Bizarre, One Just Crazy

April 1, 2016
PharmaPhorum patient opinion leaders
BusinessSocial MediaWellness

pharmaphorum: Patient Opinion Leaders Are the New Healthcare Influencers

June 18, 2014
Dr. Mike Sevilla
BusinessGlobal HealthcareSocial Media

Dr. Anonymous: Blogger, Podcaster, Early Adopter [PODCAST]

September 29, 2014
Subscribe
Subscribe to our newsletter to get our newest articles instantly!
Follow US
© 2008-2025 HealthWorks Collective. All Rights Reserved.
  • About
  • Contact
  • Privacy
Welcome Back!

Sign in to your account

Username or Email Address
Password

Lost your password?